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Women with a Reduced Ovarian Complement May Have an Increased
Risk for a Child with Down Syndrome
Sallie B. Freeman,1 Quanhe Yang,2 Katherine Allran,1 Lisa F. Taft,1 and Stephanie L. Sherman1
1Department of Genetics, Emory University School of Medicine, and 2Birth Defects and Pediatric Genetics Branch, National Center for
Environmental Health, Centers for Disease Control and Prevention, Atlanta
Advanced maternal age is the only well-established risk factor for trisomy 21 Down syndrome (DS), but the basis
of the maternal-age effect is not known. In a population-based, case-control study of DS, women who reported
surgical removal of all or part of an ovary or congenital absence of one ovary were significantly more likely to
have delivered a child with DS than were women who did not report a reduced ovarian complement (odds ratio
9.61; 95% confidence interval 1.18–446.3). Because others have observed that women who have had an ovary
removed exhibit elevated levels of FSH and similar hallmarks of advanced maternal age, our finding suggests that
the physiological status of the ovary is key to the maternal-age effect. In addition, it suggests that women with a
reduced ovarian complement should be offered prenatal diagnosis.
Although advanced maternal age is a well-established
risk factor for trisomy 21 Down syndrome (DS) (MIM
190685), much remains to be learned about the basis of
the maternal-age effect. For example, the question of
whether the chronological age of the mother or the phys-
iological age of the ovary is more important has both
biological and clinical relevance. If oocyte depletion with
advancing age is the basis of the maternal-age effect, as
is suggested by Warburton (1989), then women who
have a reduced number of oocytes for other reasons
might have an increased risk for a conception with tri-
somy 21. In this regard, it is not unusual for women to
have ovarian surgery for a variety of conditions, and,
because of associated infertility, a number of these
women become candidates for in vitro fertilization (IVF)
(Khalifa et al. 1992). The present study of the ovarian
status of women who have had a child with DS provides
clues to the nature of the maternal-age effect and sug-
gests a risk factor that may be of clinical importance to
a significant number of women.
This work is part of an ongoing population-based,
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case-control study of trisomy 21 in Atlanta. During
1989–1998, live-born infants with trisomy 21 were as-
certained with the assistance of the Metropolitan Atlanta
Congenital Defects Program (MACDP) of the Centers
for Disease Control and Prevention (Edmonds et al.
1981). Of the 372 live-born infants with DS, 267 were
enrolled in the study (participation rate 72%). In ad-
dition, the MACDP randomly selected 576 unaffected,
live-born control infants from the same population.
These infants were selected in proportion to the expected
number of total births at each hospital. The parents of
347 of the control infants enrolled in the study (60%
participation rate). Institution-approved informed con-
sent was obtained from each participant. For all DS
cases, DNA extracted from blood samples from the par-
ent(s) and child was used to determine the parent and
meiotic stage of origin of the chromosomal error (Lamb
et al. 1996; Yang et al. 1999). A questionnaire—covering
demographic factors, environmental exposures, and
medical, reproductive, and family history—was admin-
istered to the parents of case and control infants. Moth-
ers were asked whether, prior to the date of conception
of the case or control infant, they had ever had an ovary
removed. If they reported a history of ovarian surgery,
we sought medical records to verify the details. Because
various types of surgery were reported and one woman
had no surgery but only congenital absence of one ovary
(table 1), we designated the entire group as having a
reduced ovarian complement (ROC).
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Table 1
Profile of ROC Cases and Controls
Subjecta
Origin of Non-
disjunctionb
Maternal Age at
Birth of Proband
(years)
Maternal Age at
Ovarian Surgery
Menstrual
Cycle Length
(d)c Clinical Description
C152 Control 25 24 28 Unilateral salpingo-oophorectomy
for tubal pregnancy
D461 MMI 39 Not applicable 28 Congenital absence of right ovary
and tube detected at cesarean
delivery of proband
D571 MMI 32 17 28 Oophorectomy for 9094-gm ovar-
ian cyst
D602 MMI 32 30 32 Left oophorectomy for 120-cm2
cyst involving entire left ovary
D611 MMII 28 23 28 Bilateral cystectomies for endome-
triosis; removal of one half of
left ovary and one third of right
D698 MMI 36 23 25 Surgery for infertility: laparos-
copy, reduction in size of both
ovaries and removal of ob-
structing tissue from tubes
D852 MMI 33 31 30 Right salpingo-oophorectomy for
hemorrhagic corpus luteal cyst
D942 MMI 31 14 28 Left salpingo-oophorectomy for
benign teratoma; 1-cm wedge
biopsy of right ovary
a C = control subject; D = case patient.
b MMI = maternal meiosis I; MMII = maternal meiosis II.
c Mean cycle length for control mothers without ROC, d; mean cycle length for case mothers without ROC,28.6 5 2.68
d.28.19 5 2.27
The cases in this report are those for which DNA
studies were sufficiently complete to provide information
on parent and stage of origin. Because all ROC cases
were found to be the result of maternal meiotic nondis-
junction, we included in the statistical analysis only the
189 maternal cases; that is, we omitted cases of paternal,
mitotic, or unknown origin. Of the 347 control subjects
who agreed to participate, 329 had completed interviews
at the time of this report. Because of the small number
of subjects with ROC among cases and controls, the
asymptotic x2 distribution of test statistics used by the
conventional logistic regression may not hold. There-
fore, we used conditional exact inference to estimate
exact odds ratios (OR) and 95% confidence intervals
(CI) while adjusting for maternal age (seven age groups
[in years]: !15, 15–19, 20–24, 25–29, 30–34, 35–39,
and >40) and maternal race (white or other [other in-
cludes 83% black]). The adjusted exact OR and 95%
CI were estimated by means of LOGXACT software
(Cytel 1996).
Table 1 provides details on each mother with ROC
including seven cases (7/189) and one control (1/329).
A significantly greater number of mothers of infants with
DS (7/189) reported ROC than did mothers of control
infants (1/329). The adjusted OR was 9.61 (95% CI
1.18–46.3).
Brook et al. (1984) were the first to suggest that a
unilateral oophorectomy (ULO) could be a risk factor
for DS. Observing that mice with a ULO had a pre-
mature onset of cycle irregularity and an early rise in
aneuploidy, they concluded that the risk for DS is de-
termined by the distance in time from the menopause
(physiological age) rather than the chronological age of
the mother and that the number of follicles limits the
reproductive life span. Similarly, Warburton (1989) sug-
gested that, if oocyte depletion is the major factor in
age-related nondisjunction in humans, women who have
had a trisomic conception at a young age might exhibit
signs of early oocyte depletion, such as premature
menopause.
Since the original report in mice, other studies have
reported evidence of decreased reproductive fitness in
women with a ULO. Many changes seen in these women
are also seen with advancing maternal age in women
with two ovaries. For example, higher FSH (Khalifa et
al. 1992; Backer et al. 1999), lower estrogen (Lass et al.
1997), and shorter menstrual cycles (Hardy and Kuh
1999), hallmarks of advanced maternal age, have also
been associated with ULO. These similarities suggest
that age-related changes may be a matter of physiolog-
ical rather than chronological age. There is evidence
from IVF procedures that compensatory follicle growth
occurs after ULO. Some studies have found that the
number of follicles retrieved from women with one ovary
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is similar to the number obtained from women with two
ovaries (Alper et al. 1985; Hornstein et al. 1989), while
others have reported that the number of retrievable fol-
licles is decreased after ULO but is still more than half
the number expected in women with two ovaries (Dia-
mond et al. 1984; Boutteville et al. 1987). This com-
pensatory follicle recruitment and growth may further
contribute to a shorter reproductive life span in women
with ULO (Cramer et al. 1995; Hardy and Kuh 1999).
Although many reports describe the reproductive
status of women with ULO, no other studies, known to
us, discuss the incidence of aneuploidy in these women.
However, two recent reports have indicated that women
who have had an aneuploid conceptus exhibit elevated
serum FSH (van Montfrans et al. 1999; Nasseri et al.
1999). The present report of increased aneuploidy with
ROC suggests that the physiological status of the
ovary—and, more specifically, the number of folli-
cles—may be a key factor in maternal meiotic nondis-
junction. Whether, in turn, oocyte depletion is due to
the passage of time or to maternal factors such as ROC
or environmental exposures may be individually
determined.
Our findings are consistent with the limited oocyte
pool hypothesis proposed by Warburton (1989), which
states that an oocyte in a suboptimal state of develop-
ment could become the dominant follicle because of the
small number of oocytes available in older women. An
oocyte of this type might be more likely to exhibit chro-
mosome nondisjunction. The challenge still remains to
determine exactly how a depleted oocyte pool could lead
to recruitment of an oocyte destined to undergo non-
disjunction when meiosis resumes.
Finally, in addition to providing key information
about the maternal-age effect, our findings, if confirmed,
have important clinical implications, because they sug-
gest that women with less than two intact ovaries be-
cause of surgery or congenital anomalies should be of-
fered prenatal testing for chromosome abnormalities.
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